Detail akcie Sartorius stedim online

Business Summary: Sartorius Stedim Biotech SA is a France-based international provider of laboratory and process technologies and equipment. The Company covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The Company operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Sartorius Stedim Biotech SA revenues increased 8% to EUR2.2B. Net income applicable to common stockholders increased 69% to EUR218.5M. Revenues reflect EMEA segment increase of 8% to EUR921.3M, Americas segment increase of 9% to EUR781.8M, Asia/Pacific-Oceania segment increase of 7% to EUR492.1M. Net income benefited from Biopharma segment income increase of 42% to EUR405M.